Noticias de CNSP_US

Noticias del mercado

Últimas noticias sobre CNSP_US — 24 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CNSP_US ✕ 24 resultados
23/04/2026 CNSP_US — sonla.gov.vn
CNS Pharmaceuticals Inc. (CNSP) shares fall 3.27% after posting a far wider than expected Q4 2025 per-share loss.
23/04/2026 CNSP_US — Xã Thanh Hà ES ← EN
Las acciones de CNS Pharmaceuticals Inc. (CNSP) caen un 3,27% después de registrar una pérdida por acción mucho mayor de lo esperado en el cuarto trimestre de 2025.
22/04/2026 CNSP_US — haiphong.gov.vn ES ← EN
Las acciones de CNS Pharmaceuticals Inc. (CNSP) caen un 3,27% después de registrar una pérdida por acción mucho mayor de lo esperado en el cuarto trimestre de 2025.
18/04/2026 CNSP_US — sonla.gov.vn
Is CNS Pharma (CNSP) stock showing technical strength (Smart Money Outflows) 2026-04-18 - Trader Community Insights
18/04/2026 CNSP_US — vinhcong.tayninh.gov.vn ES ← EN
¿Las acciones de CNS Pharma (CNSP) muestran fortaleza técnica (salidas de dinero inteligentes)? 2026-04-18 - Trader Community Insights
17/04/2026 CNSP_US — Stock Titan
Ikarian group holds 5.7% of CNS Pharmaceuticals (NASDAQ: CNSP)
06/04/2026 CNSP_US — news.google.com
Is CNS Pharma (CNSP) Stock Underperforming | CNSP Q4 Earnings: Misses Estimates by $4.96 - Market Hype Signals
06/04/2026 CNSP_US — news.google.com
Is CNS Pharma (CNSP) Stock Underperforming | CNSP Q4 Earnings: Misses Estimates by $4.96 - Market Share
31/03/2026 CNSP_US — TradingView
CNS Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
11/03/2026 CNSP_US — Yahoo Finance
CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
11/03/2026 CNSP_US — Stock Titan
CNS Pharma shifts from single cancer focus to hunting new brain and tumor drugs
11/03/2026 CNSP_US — TipRanks ES ← EN
CNS Pharmaceuticals revela un giro estratégico hacia una oncología más amplia
11/03/2026 CNSP_US — The Globe and Mail
CNS Pharmaceuticals (NASDAQ: CNSP) Launches New Growth Strategy Focused On Neurology and Oncology Pipeline Expansion
11/03/2026 CNSP_US — Investing.com
CNS Pharmaceuticals shifts focus to neurology, oncology assets
11/03/2026 CNSP_US — GuruFocus ES ← EN
CNSP implementa una nueva estrategia para mejorar la neurología y la oncología P
02/03/2026 CNSP_US — Stock Titan
Brain cancer drug developer hires veteran surgeon to lead studies
02/03/2026 CNSP_US — Yahoo Finance
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team
02/03/2026 CNSP_US — TipRanks
CNS Pharmaceuticals Appoints New Chief Medical Officer
17/02/2026 CNSP_US — Investing.com
CNS Pharmaceuticals appoints three new executives to leadership team
17/02/2026 CNSP_US — Yahoo Finance
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

Página 1 de 2

keyboard_arrow_up